Systematic literature review and network meta-analysis of pembrolizumab versus other interventions for previously untreated, unresectable or metastatic, MSI-high or MMR-deficient CRC
Jin, He, Amonkar, Mayur, Aguiar-Ibáñez, Raquel, Thosar, Manasi, Chase, Monica, Keeping, Sam
Published in Future oncology (London, England) (01.06.2022)
Published in Future oncology (London, England) (01.06.2022)
Get full text
Journal Article